Rhee, Eugene P.

Metabolite profiles and the risk of developing diabetes

Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine

Metabolomics and Mass Spectrometry StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,143

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsMetabolomics and Mass Spectrometry Studies

Cited by 647

Metabolic signatures of exercise in human plasma

Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., et al. (2010) · Science Translational Medicine

Metabolomics and Mass Spectrometry StudiesCardiovascular and exercise physiology

Cited by 432

A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction

Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology

Metabolomics and Mass Spectrometry StudiesChronic Kidney Disease and Diabetes

Cited by 307

Metabolomics and Cardiovascular Biomarker Discovery

Rhee, E. P., & Gerszten, R. E. (2012) · Clinical Chemistry

Metabolomics and Mass Spectrometry StudiesHealth, Environment, Cognitive Aging

Cited by 232